Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
Memorial Sloan Kettering Cancer Center · Japanese Foundation For Cancer Research
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
992
total citations
- FWCI
- 53.43
- Percentile
- 100%
- References
- 39
Citations per year
Authors
9- AYAkihiko YoshizawaCorresponding
Memorial Sloan Kettering Cancer Center
- NMNoriko Motoi
Memorial Sloan Kettering Cancer Center, Japanese Foundation For Cancer Research
- GJGregory J. Riely
Memorial Sloan Kettering Cancer Center
- CSCami S. Sima
Memorial Sloan Kettering Cancer Center
- WLWilliam L. Gerald
Memorial Sloan Kettering Cancer Center
Topics & keywords
Topics
Keywords
- Adenocarcinoma
- Medicine
- Lung cancer
- Stage (stratigraphy)
- Internal medicine
- Lymph node
- Oncology
- Lung
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.